DALLAS--(BUSINESS WIRE)--Form Bio, the breakthrough AI-powered drug discovery platform, announced today its notable achievements and product advancements for the first half of 2023. The company’s ...

If you were tasked with resurrecting an extinct animal, where would you even begin? Colossal Biosciences, a synthetic biology company founded in 2021 by a Harvard geneticist George Church and ...

Google Cloud's Multiomics Suite Delivers Powerful AI and Bioinformatics Tools for Biotech Companies, Pharmaceutical Firms, and Public Sector Organizations DALLAS, TX / ACCESSWIRE / May 17, 2023 / Form ...

When George Church, PhD, and co-founders established Colossal Biosciences, they envisioned applying their advancements in CRISPR gene editing to the loss of biodiversity, species preservation, and ...

Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...

AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate ...

DALLAS, Texas--(BUSINESS WIRE)--Colossal Biosciences, the de-extinction company behind the woolly mammoth and thylacine, today announced the launch of Form Bio, a new independent company offering a ...

As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform. The software company was developed ...

Form Bio, the breakthrough computational life sciences platform, announced that it has been selected to help organizations adopt Google Cloud's Multiomics Suite, accelerating the research of life ...